In the last few years, targeted immunotherapy for haematological diseases has been developed to reduce the toxicity of chemotherapy and to improve treatment efficacy. 1 As the prognosis of B-acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results